Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drug...

Vertex Pharmaceuticals Inc (VRTX) has a valuation score of 55/100 (moderate), profitability score of 82/100 (strong), financial health score of 100/100 (strong), Piotroski F-Score of 6/9, Altman Z-Score of 13.08 (safe zone), revenue growth of +10.3% YoY.

Neutral

Analyst Consensus

Strong Buy

Wall Street consensus estimates — not a PMP forecast · Updated Sep 1, 2026

Analyst Recommendations37 analysts · 2026-08-01
11
19
6
Strong Buy 11Buy 19Hold 6Sell 0Strong Sell 1

Recent Market Moves

See all VRTX moves →
DateSessionPriceMoveZ-Score
Aug 10Pre-market$533.20+7.48%4.99
Vertex Pharmaceuticals Inc (VRTX) Valuation & P/E History →Vertex Pharmaceuticals Inc (VRTX) Financial Statements →
Share:

Explore More Stocks

AAPLMSFTNVDAGOOGLAMZNMETATSLAJPMWMTVView all stocks →